A structural rationale for the design of water soluble peptide-derived neurokinin-1 antagonists

Journal of Receptor and Signal Transduction Research

Volumn 17, Issue 6, 1997, Pages 855-873

  Jacoby, Edgar ^a   Boudon, Alain ^a   Kucharczyk, Nathalie ^a   Michel, André ^a   Fauchère, Jean Luc ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROKININ 1 RECEPTOR ANTAGONIST; S 18523; S 19752; UNCLASSIFIED DRUG;

ARTICLE; DRUG CONFORMATION; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SOLUBILITY;

EID: 0030734766     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899709039160     Document Type: Article

References (37)

1. Regoli, D.; Boudon, A. and Fauchère, J.L. Receptors and antagonists for substance P and related peptides, Pharmacol.Rev. 46, 551-599, 1994.
2. McLean, S. Nonpeptide antagonists of the NK1 tachykinin receptor, Med.Res.Rev. 16, 297, 1996.
3. Ward, P.; Armour, D.R.; Bays, D.E.; Evans, B.; Giblin, G.M.P.; Heron, N.; Hubbard, T.; Liang, K.; Middlemiss, D.; Mordaunt, J.; Naylor, A.; Pegg, N.A.; Vinader, M.V.; Watson, S.P.; Bounta, C. and Evans, D.C. Discovery of orally bioavailable NK1 receptor antagonist, (2S,3S)-(2 methoxy-5-tetrazol-1 -ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with potent antiemetic activity, J.Med.Chem. 38, 4984-4992, 1995.
4. Bonnet, J.; Kucharczyk, N.; Robineau, P.; Lonchampt, M.; Dacquet, C., Regoli, D.; Fauchère, J.L. and Canet, E. A water-soluble, stable dipeptide NK1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523, Eur.J.Pharmacol. 310, 37-46, 1996.
5. Fauchère, J.L.; Kucharczyk, N.; Jacoby, E.; Lonchampt, M.; Robineau, P.; Dacquet, C.; Regoli, D. and Canet, E. The dipeptide neurokinin-1 receptor antagonist S19752 is a potent and long-acting inhibitor of bronchoconstriction when administered by aerosol to the guina pig, Bioorg.Med.Chem.Lett. 7,203-208,1997.
6. Fujii, T.; Murai, M.; Morimoto, H.; Maeda, M.; Yamaoka, D.; Hagiwara, D.; Miyake, H.; Igari, N. and Matsuo, M. Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist FK888, Br.J.Pharmacol. 107, 785-789, 1992.
7. MacLeod, A.M.; Merchant, K.J.; Cascieri, M.A.; Sadowski, S.; Ber, E.; Swain, C.J. and Baker, R. N-acyl-L-tryptophan-benzyl esters: potent substance P receptor antagonists, J.Med.Chem. 36, 2044-2045, 1993.
8. Snider, R.M.; Longo, K.P.; Drozda, S.E.; Lowe, J.A., III and Leeman, S.E. Effect of CP96345, a nonpeptide substance P (NK1) receptor antagonist, on salivation in rats, Proc.Natl.Acad.Sci.USA 88, 10042-10044, 1991.
9. Fong, T.M.; Huang, R.C.; Yu, H.; Swain, C.J.; Underwood, D.; Cascieri, M.A. and Strader, C.D. Mutational analysis of neurokinin receptor function, Can.J.Physiol.Pharmacol. 73, 860-865, 1995.
10. Gether, U.; Lowe, J.A. and Schwartz, T.W. Tachykinin non-peptide anatgonists: binding domain and molecular mode of action, Biochem.Soc.Trans. 23, 96-102, 1995.
11. SYBYL v.6.2 Tripos Associates, Inc. St. Louis, MO.
12. Stewart, J.J.P. MOPAC: a semiempirical molecular orbital program, J.Comp.-Aided Mol.Design 4, 1-105, 1990.
13. Hibert, M.F.; Trumpp-Kallmeyer, S.; Hoflack, J. and Bruinvels, A. This is not a G protein coupled receptor, Trends Pharm. Sci. 14,7-12, 1993.
14. Ballesteros, J.A. and Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Meth. Neurosci. 25, 366-428, 1995.
15. Donnelly, D.; Findlay, J.B.C. and Blundell, T.L. The evolution and structure of aminergic G protein-coupled receptors, Recept.Channel. 2, 61-78, 1994.
16. Röper, D.; Jacoby, E.; Krüger, P.; Engels, M.; Grötzinger, J.; Wollmer, A. and Straßburger, W. Modelling of G protein coupled receptors with bacteriorhodopsin as a template, J.Receptor Res. 14, 167-186, 1994
17. Röper, D.; Krüger, P.; Grötzinger, J.; Wollmer, A. and Straßburger, W. Models of G protein coupled receptors revised for family-wide compliance with experimental data. A new sequence accommodation suggested for helix G, Recept.Channel. 3, 97-106,1995.
18. Röper, D., Erstellung molekularer Strukturmodelle für G Protein-gekoppelte Rezeptoren in Anlehnung an die Helixbündelstruktur des Bakteriorhodopsins, Ph.D. Thesis, RWTH Aachen, 1995.
19. Henderson, R.; Baldwin, J.; Ceska, T.; Zemlin, F.; Beckmann, E. and Downing, K. Model for the structure of bacteriorhodopsin based on high-resolution electron cryomicroscopy, J.Mol.Biol. 213 , 899-929, 1990.
20. Altenbach, C.; Marti, T.; Gobind Kkorana, H. and Hubbell W. Tansmembrane protein structure: spin labeling of bacteriorhodopsin mutants, Science 248, 1088-1092.
21. Dunbrack, R.L., Jr. and Karplus, M. Backbone dependent rotamer library for proteins. Application to side chain prediction, J.Mol.Biol. 230, 543-574, 1993.
22. Swain, C.J.; Seward, E.M.; Cascieri, A.; Fong, T.M.; Herbert, R.; Maclntyre, D.E.; Merchant, K.J.; Owen, S.N.; Owens, A.P.; Sabin, V.; Teall, M., VanNiel, M.B.; Williams, B.J.; Sadowski, S.; Strader, C.; Ball, R.G. and Baker, R. Identification of a series of 3-(benzyloxy)-azabicyclo [2.2.2] octan human NK1 antagonists, J.Med.Chem. 38, 4793-4805, 1995.
23. Lowe, III, J.A., Drozda, S.E., Snider, R.M., Longo, K.P., Zorn, S.H., Morrone, J.; Jackson, E.R.; McLean, S.; Bryce, D.K.; Bordner, J.; Nagahisa, A.; Kanai, Y.; Suga, O. and Tsuchiya, M. The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-((2-methoxyphenyl)methyl)-1-azabicyclo[2.2.2] octan-3-amine as a novel, non-peptide substance P antagonist, J.Med.Chem. 35, 2591-2600, 1992.
24. Boks, G.J.; Tollenaere, J.P. and Kroon, J. Possible ligand-receptor interactions for NK1 antagonists as observed in their crystal structures, Bioorg.Med.Chem.Lett. 5, 535-547, 1997.
25. Caliendo, G.; Grieco, P.; Perissutti, E.; Santagada, V.; Saviano, G.; Tancredi, T. and Temussi, P.A. Conformational analysis of three NK1 tripeptide antagonists: a proton nuclear magnetic resonance study, J.Med.Chem. 40, 594-601, 1997.
26. Desai, M.C., Vincent, L.A. and Rizzi, J.P. Importance of parallel vectors and "Hydrophobic Collapse" of the aligned aromatic rings : Discovery of a potent substance P antagonist, J.Med.Chem. 37 , 4263-4266, 1994.
27. Veenstra, S.J.; Hauser, K. and Betschart, C. Studies on the active conformation of the NK1 antagonist CGP49823. Part 1. Studies of conformationally restricted analogues, Bioorg.Med.Chem.Lett. 7,347-350,1997.
28. Veenstra, S.J.; Hauser, K. and Felber, P. Studies on the active conformation of the NK1 antagonist CGP49823. Part 2. Fluoro-olefin analogues of tertiary amide rotamers, Bioorg.Med.Chem.Lett. 7,351-354,1997.
29. Elling, C.E., Nielsen, S.M. and Schwartz, T.W. Conversion of antagonist binding site to metal ion site in the tachykinin NK-1 receptor, Nature 374, 74-77, 1995.
30. Cascieri, M.A.; Fong, T.M. and Strader, C.D. Identification of critical functional groups within binding pockets of G protein-coupled receptors, Drugs Future 21, 521-527, 1996.
31. Gether, U.; Emonds-Alt, X.; Brelière, J.C.; Fujii, T.; Hagiwara, D.; Pradier, L.; Garret, C.; Johansen, T.E. and Schwartz, T.W. Evidence for a common molecular mode of action for chemically distinct nonpeptide anatgonists at the neurokinin-1 (substance P) receptor, Mol.Pharmacol. 45, 500-508, 1993.
32. Cascieri, M.A.; MacLeod, A.; Underwood, D.; Shiao, L; Ber, E.; Sadowski, S.; Yu, H.; Merchant, K.J.; Swain, C.J. ; Strader, C. and Fong, T.M. Characterisation of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor, J.Biol.Chem. 269, 6587-6591,1994.
33. Kristiansen, K., Dahl, S. and Edvardsen, O. A database of mutants and effects of site-directed mutagenesis experiments on G protein-coupled receptors, Proteins Struct.Funct.Genet. 26, 81-94, 1996.
34. Elling, C.E. and Schwartz, T.W. Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering, EMBO J. 15, 6213-6219, 1997.
35. Schwartz, T. W. and Rosenkilde, M. M. Is there a 'lock' for all agonist 'keys' in 7TM receptors? Trends Pharmacol.Sci. 17, 213-215, 1996.
36. Bourne, H.R. How receptors talk to trimeric G proteins. Curr.Opin.Cell Biol. 9,134-142,1997.
37. Subramaniam, S.; Faruqi, A.R.; Oesterhelt, D. and Henderson, R. Electron diffraction studies of light-induced conformational changes in the Leu-93-Ala bacteriorhodopsin mutant, Proc.Natl.Acad.Sci. USA 94,1767-1772, 1997.